United Therapeutics
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
55 T.w. Alexander Dr, Durham, North Caro...Website
www.unithermedaffairs.comRevenue
<$5 MillionIndustry
About United Therapeutics
Is United Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at United Therapeutics
Check if United Therapeutics has recently received funding, and reach out quickly before it becomes old news!
United Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once United Therapeutics has new funding data
Earning: See what the market has to say on United Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if United Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if United Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when United Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined United Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to United Therapeutics
Compare insights from companies similar to United Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
United Therapeutics
Company Profile Activity
Activity Insights
United Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
United Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about United Therapeutics.
United Therapeutics Tech Stack
A closer look at the technologies used by United Therapeutics
United Therapeutics News & Media
United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced full enrollment of the TETON 2 study evaluating the use of Tyvaso® (treprostinil) inhalation solution (nebulized Tyvaso) for the treatment of idiopathic pulmonary fibrosis (IPF). The TETON 2 study enrolled 597 patients and is part of the three-study global TETON clinical trial program evaluating the use of inhaled treprostinil in IPF and a sUnited Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the first patient has enrolled in the registration-phase TETON PPF study, which will evaluate nebulized Tyvaso® (treprostinil) Inhalation Solution in 698 adult patients with progressive pulmonary fibrosis (PPF). This is in addition to two separate ongoing registration-phase studies, TETON 1 and TETON 2, of nebulized Tyvaso in pati
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding United Therapeutics
Healthcare professionals can visit United Therapeutics Global Medical Affairs online to find UT-sponsored clinical research, learn about UT grant and sponsorship opportunites, and connect with medical professionals regarding UT products.... Read More